SomaCeuticals Acquires Rights to Formula Targeting Lesions in MS & Getting a Flu Shot This Year

Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses SomaChemical’s recently acquired right to the patented formula that aims to ease and eliminate neurodegeneration in people with MS. Plus, Multiple Sclerosis News Today’s columnist and forums moderator, Ed Tobias, reports on why health officials say getting a flu shot this year is more important than ever.

=====================================

Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
http://ChangesInRMS.com

=====================================

Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/

=====================================

To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/